rimantadine has been researched along with Carcinoma, Hepatocellular in 1 studies
Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffin, S | 1 |
| Stgelais, C | 1 |
| Owsianka, AM | 1 |
| Patel, AH | 1 |
| Rowlands, D | 1 |
| Harris, M | 1 |
1 other study available for rimantadine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
Topics: 1-Deoxynojirimycin; Amantadine; Amino Acid Sequence; Antiviral Agents; Carcinoma, Hepatocellular; Ce | 2008 |